The "Dry Eye Syndrome Market Size, Share and Trends Analysis by Region, Product, Therapy Area, Distribution Channel and Segment Forecast, 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The dry eye syndrome market size was valued at US$5,465.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% during 2022-2027. The dry eye syndrome market report provides an executive-level overview of dry eye syndrome worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the global dry eye syndrome market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

Key Highlights

The major factors contributing to the market growth includes, rise in ageing population, growth in eye care centers to handle the rising burden of ophthalmological disorders, increasing research and development.

Scope

• Overview of dry eye syndrome including industry trends, deals, and product & company profile
• dry eye syndrome market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, dosage form, distribution channel, and geographic segments
• Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the key product segments
• Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the dosage form segment. Dry eye syndrome market outlook: analysis as well as forecasts of revenue opportunities from the distribution channel segment
• The competitive landscape: an examination of the positioning of leading players in dry eye syndrome market

Trends, Drivers, and Challenges

Market Trends

• Increasing public-private initiatives leading to early diagnosis and treatment of dry eye syndrome
• Growing prevalence of dry eye syndrome

Market Drivers

• Rise in Ageing Population
• Growth in eye care centers to handle the Rising burden of ophthalmological disorders
• Increasing Research & Development and promising pipeline products

Market Challenges

• High cost of specialty dry eye products
• Alternative therapies

Market Opportunities

• Demand for therapies with enhanced delivery systems
• Creating Appropriate Clinical Trial Design

Current and Future Players

• Allergan
• Aldeyra Therapeutics
• Aurinia Pharmaceuticals
• Kala Pharmaceuticals
• Mitotech
• Novartis
• RegeneRX Biopharmaceuticals/ReGenTree
• Sun Pharmaceutical

Competitive Assessment

• Cyclosporine
• LFA-1 Antagonist
• Mucin Secretagogue
• Corticosteroids
• Artificial Tears
• Autologous Serum

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Disease Overview

4 Disease Management

5 Competitive Assessment

6 Unmet Needs and Opportunity Assessment

7 Pipeline Assessment

8 Dry Eye Syndrome Industry Analysis

9 Global Dry Eye Syndrome Revenue Opportunity

10 Dry Eye Syndrome Product Outlook

11 Dry Eye Syndrome Dosage Form Outlook

12 Dry Eye Syndrome Distribution Channel Outlook

13 Dry Eye Syndrome by Regional Outlook

For more information about this report visit https://www.researchandmarkets.com/r/180jp1-eye-syndrome?w=4

Source: GlobalData

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005514/en/